Viewing Study NCT00004060


Ignite Creation Date: 2025-12-25 @ 2:15 AM
Ignite Modification Date: 2026-05-23 @ 2:43 PM
Study NCT ID: NCT00004060
Status: COMPLETED
Last Update Posted: 2012-05-16
First Post: 1999-12-10
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Chemotherapy in Treating Patients With Recurrent, Metastatic, or Unresectable Ovarian, Fallopian Tube, or Peritoneal Cancer
Sponsor: Daiichi Sankyo
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Fallopian Tube Cancer View
None Ovarian Cancer View
None Primary Peritoneal Cavity Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None stage III ovarian epithelial cancer View
None stage IV ovarian epithelial cancer View
None recurrent ovarian epithelial cancer View
None fallopian tube cancer View
None primary peritoneal cavity cancer View